Resonance Health (Australia) Insiders

Resonance Health Management Team Effectiveness

The company has return on total asset (ROA) of (0.0519) % which means that it has lost $0.0519 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1705) %, meaning that it generated substantial loss on money invested by shareholders. Resonance Health's management efficiency ratios could be used to measure how well Resonance Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Resonance Health's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 18.8 M in 2025, whereas Non Current Liabilities Total is likely to drop slightly above 2.5 M in 2025. Common Stock Shares Outstanding is likely to drop to about 317.5 M in 2025. Net Loss is likely to gain to about (1.6 M) in 2025

Resonance Health Workforce Comparison

The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.05) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.05.

Resonance Health Benchmark Summation

Resonance Health Notable Stakeholders

The success or failure of an entity such as Resonance Health often depends on how effective the management is. Resonance Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Resonance management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Resonance management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Resonance Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Resonance Health. Check Resonance Health's Beneish M Score to see the likelihood of Resonance Health's management manipulating its earnings.

When running Resonance Health's price analysis, check to measure Resonance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resonance Health is operating at the current time. Most of Resonance Health's value examination focuses on studying past and present price action to predict the probability of Resonance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resonance Health's price. Additionally, you may evaluate how the addition of Resonance Health to your portfolios can decrease your overall portfolio volatility.